Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
NCT00919217 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2026-04-15
Summary
The investigators' overall hypothesis is that appearance or worsening of relapsing-remitting multiple sclerosis (RR-MS) symptoms are affected by various factors including stress, hormonal cycles, illness and missed medications.
Conditions
- Relapsing Remitting Multiple Sclerosis
Sponsors & Collaborators
-
University of Louisville
lead OTHER
Principal Investigators
-
Cynthia Corbitt, PhD · University of Louisville, Dept. Biology
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2025-05-31
- Completion
- 2025-05-31
Countries
- United States
Study Locations
More Related Trials
-
Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
NCT04009005 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Risk Factors in Early Multiple Sclerosis
NCT03586986 ·Status: UNKNOWN
-
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
NCT03073603 ·Status: COMPLETED ·Phase: PHASE4
-
Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)
NCT02301247 ·Status: COMPLETED ·Phase: NA
-
Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
NCT00813969 ·Status: COMPLETED ·Phase: PHASE1
-
Intermittent Fasting in Multiple Sclerosis
NCT03539094 ·Status: COMPLETED ·Phase: NA
-
Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies
NCT01020370 ·Status: COMPLETED
-
Adherence in Pediatric Multiple Sclerosis
NCT02234713 ·Status: COMPLETED ·Phase: NA
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Observational Trial Evaluating Elevated Factor VIII Related Labs as a Biomarker for Incomplete Relapse Recovery
NCT05926167 ·Status: UNKNOWN
-
Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)
NCT00986960 ·Status: WITHDRAWN ·Phase: PHASE2
-
Development of a Motivational Intervention to Improve Treatment Adherence in MS
NCT01925690 ·Status: COMPLETED ·Phase: NA
-
Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis
NCT03302442 ·Status: COMPLETED
-
Helminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple Sclerosis
NCT00645749 ·Status: COMPLETED ·Phase: PHASE1
-
Reinventing Yourself With Multiple Sclerosis (MS)
NCT05195320 ·Status: UNKNOWN ·Phase: NA
-
Progression of Cognitive and Physical Symptoms in Multiple Sclerosis
NCT00922831 ·Status: WITHDRAWN
-
POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler
NCT01051817 ·Status: COMPLETED ·Phase: PHASE2
-
Mapping the Longitudinal, Multidimensional Impact of MS in Relation to Variables Indicative of Neurological Reserve
NCT06410326 ·Status: COMPLETED
-
Comprehensive Analysis of Relapse in Multiple Sclerosis
NCT01906684 ·Status: UNKNOWN ·Phase: NA
-
Investigation of Subclinical Markers of Multiple Sclerosis
NCT04604041 ·Status: RECRUITING
-
Genes and Environment in Multiple Sclerosis
NCT01353547 ·Status: RECRUITING
-
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
NCT04380220 ·Status: UNKNOWN
-
Clinical Importance of Glucose Regulation in Relapsing MS
NCT03004079 ·Status: UNKNOWN
-
Immunoadsorption Versus High-dose Intravenous Corticosteroids in Relapsing Multiple Sclerosis
NCT04450030 ·Status: UNKNOWN
-
Relationship Between the Nutritional Habits and Relapsing and Disability Rates in Patient With Multiple Sclerosis.
NCT04110171 ·Status: UNKNOWN